Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Radiosensitizing effect of hyperfractionated radiation].

Agnes Drahos1, Annamária Dám, Zsolt Oreg

  • 1Országos "Frédéric Joliot-Curie" Sugárbiológiai és Sugáregészségügyi Kutató Intézet, Budapest 1221, Hungary. drahos@hp.osski.hu

Magyar Onkologia
|January 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Photosensitivity with Angiotensin II Receptor Blockers: A Retrospective Study Using Data from VigiBase(®).

Drug safety·2015
Same author

Oxidative stress with altered element content and decreased ATP level of erythrocytes in hepatocellular carcinoma and colorectal liver metastases.

European journal of gastroenterology & hepatology·2008
Same author

Alterations in the content of metal elements and fatty acids in hepatic ischaemia-reperfusion: induction of apoptotic and necrotic cell death.

Digestive diseases and sciences·2007
Same author

The influence of refractory ceramic fibres on pulmonary morphology, redox and immune system in rats.

Journal of applied toxicology : JAT·2006
Same author

[Histologic chorioamnionitis is associated with cerebral palsy].

Orvosi hetilap·2006

Hyperfractionated radiation therapy, using small doses (0.5 Gy) per fraction, enhances the effectiveness of radiation and radiosensitizing agents in melanoma cells. This approach significantly increases cell death compared to single high-dose treatments.

Area of Science:

  • Oncology
  • Radiation Biology
  • Cancer Research

Background:

  • Fractionated radiation therapy is a cornerstone of cancer treatment.
  • Hyperfractionation involves delivering radiation in smaller, more frequent doses.
  • The efficacy of hyperfractionation, particularly with radiosensitizing agents, requires further investigation in melanoma.

Purpose of the Study:

  • To evaluate the benefits of hyperfractionated radiation therapy in melanoma cell lines.
  • To determine if hyperfractionation influences the radiosensitizing effect of dibromodulcitol (DBD).
  • To compare cell survival and apoptosis rates between single-dose and hyperfractionated irradiation protocols.

Main Methods:

  • Two melanoma cell lines were subjected to in vitro irradiation.

Related Experiment Videos

  • Treatments included single 4 Gy fractions and hyperfractionated eight 0.5 Gy fractions.
  • Irradiation was conducted under both normoxic and hypoxic conditions, with and without dibromodulcitol.
  • Cell survival was assessed using hemocytometer cell counting and clonogenic assays.
  • Apoptosis was quantified using the TUNEL assay up to 72 hours post-treatment.

    • Main Results:

    • Hypoxic melanoma cells exhibited greater sensitivity to 0.5 Gy irradiation compared to normoxic cells.
    • The radiosensitizing enhancement of dibromodulcitol was more pronounced with fractionated irradiation.
    • Hyperfractionated treatments led to a significantly higher number of apoptotic cells than single-dose treatments.
    • Hyperfractionated irradiation at 0.5 Gy per fraction demonstrated significant efficacy in vitro.

    Conclusions:

    • Hyperfractionated irradiation, particularly with 0.5 Gy fractions, offers significant benefits in melanoma treatment.
    • This fractionation schedule enhances the radiosensitizing effects of agents like dibromodulcitol.
    • The findings support the clinical relevance of hyperfractionated radiation therapy for improving treatment outcomes in melanoma.